Atlas Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers

Clinical trial NCT00910923 · COMPLETED

Trial details

NCT number
NCT00910923
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2008-11-01
Primary completion
2009-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.